The FDA has cleared ziprasidone (Geodon) for maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate. It joins several other antipsychotic drugs -- including quetiapine ...

When taking Ziprasidone, alcohol should be avoided since it causes drowsiness, impaired driving, dizziness and an increased risk of overdose (1 Trusted Source National Institute on Alcohol and ...

There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). In a randomized, double-blind, placebo-controlled trial, we assigned ...

Learn everything you need to know about Ziprasidone-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...

March 25, 2004 — Augmentation treatment with ziprasidone may be helpful for patients with major depressive disorder (MDD) not responding adequately to selective serotonin reuptake inhibitors (SSRIs), ...

April 10, 2003 — The atypical antipsychotic ziprasidone was found to be safe and effective with rapid onset of action for the treatment of acute mania in patients with bipolar I disorder, according to ...

A new study showed no difference in nonsuicide mortality between people taking ziprasidone and another second-generation anti-psychotic in real-world use. The potential for harmful side effects ...

ICU The researchers found that patients were exposed to a trial drug or placebo for a median duration of four days. The median number of days alive without delirium or coma was 8.5, 7.9, and 8.7 in ...

The U.S. Food and Drug Administration (FDA) is warning that the antipsychotic drug ziprasidone (marketed under the brand name, Geodon, and its generics) is associated with a rare but serious skin ...

NEW YORK (Reuters Health) - Ziprasidone, sold under the trade name Geodon, is well tolerated by patients and shows long-term efficacy as maintenance therapy for patients with schizophrenia who have ...